[Effect of pharmacological agents on the radioprotective activity, toxicity and distribution of 35S-labeled aminopropylaminoethyl-thiophosphate administered perorally].
D000284:Administration, Oral; D004999:Amifostine / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D004347:Drug Interactions; D005260:Female; D005720:Gamma Rays; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009946:Organothiophosphorus Compounds / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D011837:Radiation-Protective Agents / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D013462:Sulfur Radioisotopes; D013565:Sympatholytics / Q000494:pharmacology*; D014018:Tissue Distribution
D009946:Organothiophosphorus Compounds; D010277:Parasympathomimetics; D011837:Radiation-Protective Agents; D013462:Sulfur Radioisotopes; D013565:Sympatholytics; D001285:Atropine; D004999:Amifostine
Vliianie nekotorykh farmakologicheskikh svoistv sredstv na radiozashchitnuiu aktivnost', toksichnost' i raspredelenie mechennogo po 35S aminopropilaminoétiltiofosfata pri peroral'nom sposobe vvedeniia.